<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181139</url>
  </required_header>
  <id_info>
    <org_study_id>ERASBreast</org_study_id>
    <nct_id>NCT03181139</nct_id>
  </id_info>
  <brief_title>Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy</brief_title>
  <acronym>ERAS_Breast</acronym>
  <official_title>Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monica Harbell</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mount Zion Health Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective analysis of pre and post-Enhanced Recovery after Surgery for Total mastectomy
      pathway implementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective analysis of pre- and post-Enhanced Recovery after surgery for total mastectomy
      pathway implementation in patients at Mount Zion Hospital. We examined perioperative opioid
      consumption, pain scores, post-operative nausea and vomiting, benzodiazepine use, length of
      stay for the time period before and after implementation of an Enhanced Recovery after
      Surgery pathway for Total mastectomy. Pathway features included preoperative acetaminophen
      and gabapentin, minimizing opioids, postoperative NSAIDs, Pecs blocks, and aggressive
      postoperative nausea and vomiting prophylaxis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2013</start_date>
  <completion_date type="Actual">April 30, 2016</completion_date>
  <primary_completion_date type="Actual">April 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>perioperative opioid consumption</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>perioperative opioid consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative nausea and vomiting (PONV)</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>incidence post-operative nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative benzodiazepine use</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>amount of benzodiazepines used postoperatively for treatment of muscle spasm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay (LOS)</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>Length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>highest pain score perioperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery duration</measure>
    <time_frame>through study completion (average of 1 year)</time_frame>
    <description>length of surgery (min)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">386</enrollment>
  <condition>Mastectomy</condition>
  <condition>Breast Cancer Female</condition>
  <arm_group>
    <arm_group_label>pre-ERAS</arm_group_label>
    <description>Patients cared for prior to the implementation of the Enhanced Recovery after surgery for total mastectomy pathway</description>
  </arm_group>
  <arm_group>
    <arm_group_label>post-ERAS</arm_group_label>
    <description>patients cared for after the implementation of the Enhanced Recovery after surgery for total mastectomy pathway. Pathway included preoperative acetaminophen and gabapentin, Pec blocks, multimodal analgesia postoperatively and aggressive PONV treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ERAS pathway for Total Mastectomy</intervention_name>
    <description>Enhanced Recovery after Surgery (ERAS) pathway for Total Mastectomy</description>
    <arm_group_label>post-ERAS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients at UCSF Mount Zion hospital who were scheduled for total mastectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patients at least 18 years old undergoing total skin sparing mastectomy at
             University of California San Francisco Mount Zion hospital

        Exclusion Criteria:

          -  patients undergoing concurrent bilateral salpingo-oophorectomy, flap reconstruction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Monica Harbell</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Enhanced Recovery after Surgery (ERAS)</keyword>
  <keyword>Fast-track surgery</keyword>
  <keyword>Pec Blocks</keyword>
  <keyword>Mastectomy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

